Study comparing the efficacy of dexmedetomidine as an adjuvant for post mastectomy analgesia
Phase 2
Recruiting
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/11/059958
- Lead Sponsor
- Dr Ilancheran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
American society of Anaesthesiologists(ASA) 1-3
Exclusion Criteria
Refusal to participate in the study
Age < 18 years
ASA class 4 & 5
Known coagulation disorders
Allergy to Local anaesthetics
Unconscious or mentally incompetent
Pregnancy & Hemodynamic instability
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to initial onset of pain ( VAS score greater than or equal to 4) and time to first rescue analgesia <br/ ><br>Quality of recovery after anaesthesia using the Qor 15 questionnaireTimepoint: 0 mins <br/ ><br>30 mins <br/ ><br>1 hr <br/ ><br>2 hr <br/ ><br>4 hr <br/ ><br>8 hr <br/ ><br>12 hr <br/ ><br>16 hr <br/ ><br>20 hr <br/ ><br>24 hr
- Secondary Outcome Measures
Name Time Method number of rescue analgesics usedTimepoint: over a period of 24 hours